Craig Phillips’s research focuses on how obstructive sleep apnoea (OSA) contributes to cardiometabolic diseases. He investigates the mechanisms linking OSA to conditions such as high blood pressure, insulin resistance, dyslipidaemia, and obesity, using randomized controlled trials and experimental studies to understand and treat these cardiometabolic consequences.